Trial Profile
Bipolar Comprehensive Outcomes Study
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 Jun 2007
Price :
$35
*
At a glance
- Drugs Olanzapine (Primary) ; Mood stabilisers
- Indications Bipolar I disorders; Schizoaffective disorder
- Focus Therapeutic Use
- Acronyms BCOS
- 28 Jun 2007 New trial record.